Medicine,
Journal Year:
2024,
Volume and Issue:
103(31), P. e39134 - e39134
Published: Aug. 2, 2024
Background:
Irritable
bowel
syndrome
(IBS)
is
a
major
global
healthcare
burden
that
requires
effective
and
well-tolerated
intervention.
This
study
aimed
to
investigate
the
effectiveness
safety
of
Bacillus
coagulans
BCP92,
probiotic,
in
managing
IBS
symptoms.
Methods:
randomized
controlled
trial
included
100
participants
who
strictly
adhered
protocol.
Various
parameters
such
as
severity,
digestive
symptom
frequency,
gastrointestinal
stool
consistency,
interleukin-6
levels,
stress
relief,
anxiety
levels
were
evaluated
over
12
weeks.
Results:
B.
BCP92
significantly
improved
severity
(
P
<
.001),
frequency
.001)
compared
with
control
group.
The
consistency
.001).
Mental
relief
was
remarkable
=
differentiating
test
groups.
No
significant
change
observed;
however,
assessment
revealed
an
excellent
profile
no
reported
severe
adverse
events.
Conclusion:
one
most
promising
therapeutic
options
for
management
because
it
has
shown
efficacy
alleviating
symptoms
among
patients
suffering
from
this
condition,
resulting
changes
addition
improving
overall
mental
well-being
its
users,
thereby
foreseeing
elimination
any
potential
side
effects
experienced
during
implementation
approach
strategy
within
our
health
care
system,
patient
outcomes
leading
individualization
treatment
plans
all
individuals
diagnosed
disease
entity
may
have
symptoms,
including
abdominal
pain
or
discomfort
associated
habits.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(4), P. 701 - 701
Published: Feb. 16, 2025
The
gut
microbiota
is
involved
in
modulating
gastrointestinal
function
and
consequently
contributes
to
the
manifestation
of
functional
disorders
(FGIDs).
aim
study
was
analyze
composition
infants
with
(infantile
colic,
constipation,
gastroesophageal
reflux,
diarrhea)
according
age,
environmental
factors,
clinical
manifestations.
laboratory
examination
134
divided
into
two
groups:
group
I
(n
=
82)
FGIDs
Rome
IV
criteria,
four
subgroups
diarrhea),
II
52)
without
FGIDs.
To
assess
intestinal
microbiota,
a
bacteriological
analysis
fecal
samples
performed.
Infants
presented
an
imbalance
microflora,
which
characterized
by
significant
decrease
main
representatives
acidifying
flora
represented
Lactobacillus,
Bifidobacterium,
Enterococcus
high
abundance
proteolytic
microorganisms
from
Enterobacteriaceae
family
such
as
Klebsiella
species
Escherichia
coli.
In
born
cesarean
section
or
artificially
fed,
incidence
dysbiosis
significantly
higher.
microbial
could
be
key
occurrence
first
year
life.
Nutrition Bulletin,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 4, 2025
Lifestyle
factors
such
as
diet
and
physical
activity
are
involved
in
the
development
maintenance
of
depression,
but
mechanism
by
which
these
influence
mental
health
remains
unclear.
The
aim
this
study
was
to
investigate
whether
gastrointestinal
helps
explain
some
relationship
between
lifestyle
depression.
used
a
cross-sectional
design
compare
dietary
intake,
three
groups,
healthy
(n
=
235),
lifetime
depression
161)
current
86).
Dietary
intake
measured
Fruit
And
Vegetable
VAriety
index,
N-3
PUFA
Food
Frequency
Questionnaire
Prebiotic
Probiotic
Questionnaire.
Analysis
variance,
Pearson
correlations
Hayes
PROCESS
macro
mediation
analysis
were
groups
examine
relationships.
Physical
differed
significantly
with
no
differences
overall
fruit
vegetable,
omega-3
probiotic
food
intake.
Bootstrapped
showed
that
higher
vegetable
associated
lower
symptom
scores,
effects
weak.
Furthermore,
occurrence
symptoms
moderately
scores.
Results
from
series
exploratory
analyses
suggested
mediated
status.
These
data
indicate
on
might
partly
work
through
system.
findings
help
further
understand
mechanisms
activity,
can
inform
future
longitudinal
experimental
studies.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 22, 2025
In
recent
years,
the
study
of
interaction
between
gut
microbiota
and
distant
organs
such
as
heart,
lungs,
brain,
liver
has
become
a
hot
topic
in
field
microbiology.
With
deeper
understanding
its
immune
regulation
mechanisms
action,
these
findings
have
increasingly
highlighted
their
guiding
value
clinical
practice.
The
is
not
only
largest
digestive
organ
human
body
but
also
habitat
for
most
microorganisms.
Imbalances
microbial
communities
been
associated
with
various
lung
diseases,
allergic
asthma
cystic
fibrosis.
Furthermore,
significant
impacts
on
metabolic
function
responses.
Their
metabolites
regulate
gastrointestinal
systems
may
affect
lungs
brain.
As
one
common
types
respiratory
system
diseases
worldwide,
pulmonary
infections
high
morbidity
mortality
rates.
Pulmonary
caused
by
dysfunction
can
lead
to
problems
like
diarrhea,
further
resulting
imbalances
within
complex
interactions
that
are
abnormal
manifestations
under
disequilibrium
conditions.
Meanwhile,
interventions
significantly
modulate
composition
microbiota,
alteration
subsequently
indicate
susceptibility
even
contribute
prevention
or
progression.
This
review
delves
into
infections,
elucidating
latest
advancements
gut-lung
axis
research
providing
fresh
perspective
treatment
pneumonia.
SIBO
is
a
pathology
of
the
small
intestine
and
may
predispose
individuals
to
range
nutritional
deficiencies.
Very
little
known
whether
specific
subtypes
SIBO,
such
as
hydrogen-dominant
(H+),
methane-dominant
(M+),
or
hydrogen/methane
–dominant
(H+/M+),
impact
status
dietary
intake
in
patients.
The
aim
this
study
was
investigate
possible
correlations
between
biochemical
parameters,
nutrient
intake,
distinct
subtypes.
This
observational
included
67
patients
who
were
newly
diagnosed
with
SIBO.
Biochemical
parameters
diet
studied
utilizing
laboratory
tests
food
records,
respectively.
H+/M+
group
associated
low
serum
vitamin
D
(p&lt;0.001),
ferritin
(p=0.001)
fiber
(p=0.001).
M+
correlated
high
folic
acid
(p=0.002)
intakes
lactose
(p=0.002).
H+
(p=0.027).
These
results
suggest
that
subtype
have
varying
effects
on
leading
deficiencies
body.
Conversely,
patterns
development
subtype.
assessment
diet,
along
diagnosis
substype,
are
believed
be
key
components
therapy.
Medicine,
Journal Year:
2024,
Volume and Issue:
103(31), P. e39134 - e39134
Published: Aug. 2, 2024
Background:
Irritable
bowel
syndrome
(IBS)
is
a
major
global
healthcare
burden
that
requires
effective
and
well-tolerated
intervention.
This
study
aimed
to
investigate
the
effectiveness
safety
of
Bacillus
coagulans
BCP92,
probiotic,
in
managing
IBS
symptoms.
Methods:
randomized
controlled
trial
included
100
participants
who
strictly
adhered
protocol.
Various
parameters
such
as
severity,
digestive
symptom
frequency,
gastrointestinal
stool
consistency,
interleukin-6
levels,
stress
relief,
anxiety
levels
were
evaluated
over
12
weeks.
Results:
B.
BCP92
significantly
improved
severity
(
P
<
.001),
frequency
.001)
compared
with
control
group.
The
consistency
.001).
Mental
relief
was
remarkable
=
differentiating
test
groups.
No
significant
change
observed;
however,
assessment
revealed
an
excellent
profile
no
reported
severe
adverse
events.
Conclusion:
one
most
promising
therapeutic
options
for
management
because
it
has
shown
efficacy
alleviating
symptoms
among
patients
suffering
from
this
condition,
resulting
changes
addition
improving
overall
mental
well-being
its
users,
thereby
foreseeing
elimination
any
potential
side
effects
experienced
during
implementation
approach
strategy
within
our
health
care
system,
patient
outcomes
leading
individualization
treatment
plans
all
individuals
diagnosed
disease
entity
may
have
symptoms,
including
abdominal
pain
or
discomfort
associated
habits.